rs832358
Positions:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6_Very_StrongBP7
The NM_182588.3(RGPD4):āc.3441A>Gā(p.Leu1147Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.21 ( 1825 hom., cov: 4)
Exomes š: 0.48 ( 207130 hom. )
Failed GnomAD Quality Control
Consequence
RGPD4
NM_182588.3 synonymous
NM_182588.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0780
Genes affected
RGPD4 (HGNC:32417): (RANBP2 like and GRIP domain containing 4) Predicted to contribute to GTPase activator activity. Predicted to be involved in NLS-bearing protein import into nucleus. Predicted to be part of nuclear pore. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.71).
BP6
Variant 2-107871445-A-G is Benign according to our data. Variant chr2-107871445-A-G is described in ClinVar as [Benign]. Clinvar id is 403374.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.078 with no splicing effect.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00 AC: 6689AN: 32558Hom.: 1812 Cov.: 4 FAILED QC
GnomAD3 genomes
AF:
AC:
6689
AN:
32558
Hom.:
Cov.:
4
FAILED QC
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.215 AC: 28750AN: 133662Hom.: 14070 AF XY: 0.205 AC XY: 14389AN XY: 70126
GnomAD3 exomes
AF:
AC:
28750
AN:
133662
Hom.:
AF XY:
AC XY:
14389
AN XY:
70126
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.480 AC: 426449AN: 888328Hom.: 207130 Cov.: 30 AF XY: 0.492 AC XY: 217879AN XY: 442976
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
426449
AN:
888328
Hom.:
Cov.:
30
AF XY:
AC XY:
217879
AN XY:
442976
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.206 AC: 6702AN: 32568Hom.: 1825 Cov.: 4 AF XY: 0.186 AC XY: 3013AN XY: 16212
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
6702
AN:
32568
Hom.:
Cov.:
4
AF XY:
AC XY:
3013
AN XY:
16212
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at